HRI Portal – health • research • innovation

  • About Us
    • About Research Canada
    • Sponsors
    • Contact
  • Information on Health Research
    and Innovation in Canada
    • The Current State of Health Research
      and Innovation in Canada
    • Research and Innovation in Action
    • CanadaSpeaks! 2019
    • Patient Stories
    • What’s Being Said:
      Blog and News
  • Resources for
    Advocates
    • Advocacy Messages
    • Tips for Effective Advocacy
      • Quick Tips for Effective Advocacy
      • Meeting with Candidates: Policy Questions and Answers
      • Using Social Media for Advocacy
      • Maximizing Your Impact: Town Halls
    • About Your Candidates
    • Advocates’ Toolkit
  • Resources for
    Candidates
    • Information on Health Research and Innovation
    • Candidate Survey

Patient Stories

Voir en Français
  1. Home
  2. › Information on Health Research and Innovation in Canada
  3. › Patient Stories
  4. › Sarah Rogers
Sarah Rogers

Sarah Rogers

Ottawa Hospital Research Institute


Ottawa tattoo artist Sarah Rogers thought she’d pulled a muscle when her right leg started hurting in 2011. But instead of going away, the pain got worse.

After feeling dizzy on the way to work, she went to the emergency department, where she learned her leg had a blood clot, known as venous thromboembolism. Then she was referred to The Ottawa Hospital’s thrombosis clinic for treatment.

“It was so disconcerting—there was nothing I did to make it happen,” said the 38-year-old.

About half of venous thromboembolism cases are like Rogers’, and happen for no apparent reason. The clots can be life-threatening if they travel to the lungs, so guidelines suggest that patients take blood thinners for the rest of their lives to prevent future clots.

But blood thinners come with challenges, including an increased risk of major bleeding. Like most patients, Rogers was on warfarin, which interacts with leafy greens. This meant she couldn’t eat as much kale, broccoli and spinach as she would have liked. She also had to go into the hospital once a week to check her dose of medication.

“If my blood was too thin, I felt lightheaded. If I wasn’t taking enough blood thinner, I would have pains in my leg,” she said.

However, after her clot was treated, Rogers was able to safely stop taking warfarin, thanks to a study led by Dr. Marc Rodger. His team developed a simple rule that identifies women who are at low risk of having a second blood clot, and can therefore stop taking blood thinners.

“We see two to three patients with unexplained blood clots every day at The Ottawa Hospital,” said Dr. Rodger, senior scientist and thrombosis specialist at The Ottawa Hospital and professor at the University of Ottawa. “If this rule was applied across Canada, we estimate that over 10,000 women a year would be able to come off blood thinners.”

Today Rogers is happy to be blood clot and blood thinner free.

“It was absolutely wonderful to get off the blood thinners, as much as the treatment was necessary in the short term,” she said. “I could not wait to eat a giant bowl of kale salad.”

Danielle McCullyMajor Ronald Miller

Contact Us

Tweets

  • 8 hours ago RT @ALSCanada: You can still share your views and ideas on how to shape a National Strategy for High-Cost Drugs for Rare Diseases. Make sur…
  • 8 hours ago RT @MichenerInst: During the first wave of the pandemic, Michener Respiratory Therapy alumnus Farzad Refahi was deployed to the Acute Care…
  • 8 hours ago RT @HamHealthSci: Pet therapy has been a welcoming experience for many patients in the palliative care unit at HHS' St. Peter's Hospital. B…
  • 8 hours ago In today's Media Digest: @usask researcher uses spit samples to study #COVID-19 risks in dentistry https://t.co/VhuLvLGJW5

About Research Canada

Research Canada is a national, broad-based alliance dedicated to increasing investments in health research through collaborative advocacy. We believe health research is shared benefit, shared responsibility and an investment in Canada’s future. We engage government, academia, industry and non-profit sectors to build support for balanced and long-term health research funding – investments that strengthen Canada’s innovation system and lead to better health, sustainable health care, new commercialization opportunities, and skilled jobs for Canadians.

Research Canada: An Alliance for Health Discovery / Recherche Canada : Une alliance pour les découvertes en santé
Your Candidates, Your Health Your Candidates, Your Health
HRI Portal – health • research • innovation
  • Sponsors
  • Health Research
    and Innovation
  • Resources for
    Candidates
  • Resources for
    Advocates
  • What’s Being Said:
    Blog and News
  • Contact
Research Canada/Recherche Canada © 2019 | All Rights Reserved | Tous droits réservés.